ARCTOS medical

Bern, Switzerland Founded: 2018 • Age: 8 yrs Acquired By Novartis
Optogenetic therapies for retinal degenerative diseases are developed.
Request Access

About ARCTOS medical

ARCTOS medical is a company based in Bern (Switzerland) founded in 2018 was acquired by Novartis in September 2021.. ARCTOS medical operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others.

  • Headquarter Bern, Switzerland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Novartis

    (Sep 21, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ARCTOS medical

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ARCTOS medical

ARCTOS medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
R&D focused on manufacturing of drugs for multiple therapeutic areas
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ARCTOS medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ARCTOS medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Arctos Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ARCTOS medical

ARCTOS medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecule therapeutics for ophthalmic disorders are developed.
domain founded_year HQ Location
Therapies for metabolic and orphan diseases are developed by Rezolute.
domain founded_year HQ Location
Therapeutic solutions for diseases are developed using DARPin technology.
domain founded_year HQ Location
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
domain founded_year HQ Location
Gene therapy solutions for retinal diseases are developed.
domain founded_year HQ Location
Therapies for ophthalmological diseases are developed to restore vision.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Arctos Medical

Frequently Asked Questions about ARCTOS medical

When was ARCTOS medical founded?

ARCTOS medical was founded in 2018.

Where is ARCTOS medical located?

ARCTOS medical is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.

What does ARCTOS medical do?

ARCTOS medical was founded in 2018 in Bern, Switzerland, within the biotechnology sector. Optogenetic therapies targeting retinal degenerative diseases are developed using adeno-associated virus gene therapy. Replacement photoreceptors incorporating optogenes are designed to activate specific cells in the retina. Applications focus on addressing blindness linked to conditions such as retinitis pigmentosa and age-related macular degeneration. Operations center on preclinical and clinical advancements in gene-based vision restoration.

Who are the top competitors of ARCTOS medical?

ARCTOS medical's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.

Who are ARCTOS medical's investors?

ARCTOS medical has 1 investor. Key investors include Novartis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available